1. Study of aztreonam for inhalation in children with cystic fibrosis and new infection of the airways by pseudomonas aeruginosa bacteria www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-002749-42-GR
2. Study of aztreonam for inhalation in children with cystic fibrosis and new Infection of the airways by pseudomonas aeruginosa bacteria (ALPINE 2) clinicaltrials.gov/ct2/show/NCT03219164
3. Evaluation of the efficacy and safety of tobramycin for the treatment of early infections of P. aeruginosa in cystic fibrosis subjects aged from 3 months to less than 7 years trialsearch.who.int/?TrialID=EUCTR2009-016590-15-IT
4. Randomized, controlled study of CF patients between 3 months and less than 7 years clinicaltrials.gov/show/NCT01082367
5. TOBI® for eradication of early P. aeruginosa infection in paediatric cystic fibrosis patients: the EARLY study;Ratjen;Journal of Cystic Fibrosis,2016